▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2485 by analyst upside · 2026-06-27
ARGX
argenx SE
Healthcare · Market Cap $55B · P/E 39.5x
ANALYST PRICE TARGET
+17.4%
implied upside to consensus target
Current Price $887.18
Consensus Target $1041.14
Bull Target $1291.74
Bear Target $677.36
Analysts Covering 23
ANALYST CONSENSUS - BUY
Strong Buy
6
Buy
14
Hold
3
Sell
0
52-Week Low $510.06
52-Week High $934.62
YTD Return +5.6%
FUNDAMENTALS
Market Cap $55B
P/E Ratio (TTM) 39.5x
Forward P/E 24.2x
EPS (TTM) $22.48
PEG Ratio 1.44
Dividend Yield N/A
Revenue (TTM) $4.7B
Profit Margin 31.4%
52-WEEK RANGE
52-Week Low $510.06
52-Week High $934.62
Current Price $887.18
Bear Target $677.36
Bull Target $1291.74
● Now $887.18 ● Target $1041.14
TRADING DATA
Avg Volume 343K
YTD Return +5.6%
Analyst Count 23
Consensus Buy
Upside to Target +17.4%
Last Updated 2026-06-27

ANALYST SUMMARY

argenx SE (ARGX) is currently trading at $887.18 with a Wall Street consensus price target of $1041.14, implying potential upside of 17.4% over the next 12 months. 23 analysts currently cover ARGX, with a consensus rating of Buy - 87% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1291.74, while the most cautious has a target of $677.36.

ARGX operates in the Healthcare sector with a market capitalisation of $55B. The stock is up 5.6% year-to-date and is currently trading near the upper end of its 52-week range of $510.06 – $934.62.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

EW +6.8%
Edwards Lifesciences Corporation
$52B · P/E 48.5x · Buy
CAH +3.1%
Cardinal Health, Inc.
$56B · P/E 35.8x · Buy
COR +22.7%
Cencora, Inc.
$56B · P/E 21.9x · Buy
BDX +14.0%
Becton, Dickinson and Company
$43B · P/E 26.4x · Hold
IDXX +28.6%
IDEXX Laboratories, Inc.
$44B · P/E 40.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ARGX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wedbush reit
Outperform → Outperform 2026-06-11 Building track record
Wedbush reit
Outperform → Outperform 2026-06-04 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-06-01 Building track record
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-05-15 Building track record
Guggenheim — Reiterated
Buy → Buy 2026-05-08 62% win rate (8 calls)
Wells Fargo — Reiterated
Overweight → Overweight 2026-05-08 Building track record
Oppenheimer — Reiterated
Outperform → Outperform 2026-04-02 14% win rate (7 calls)
Wedbush reit
Outperform → Outperform 2026-03-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
24/30
Consensus clarity
16/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →